Department of Clinical Pharmacy
University of California, San Francisco
3333 California Street Suite 420, Box 0613
San Francisco, CA 94118
Email: berol@pharmacy.ucsf.edu
Phone: 415-476-1067
Fax: 415-502-0792
Assistant:
Erika Campbell
Email:
campbelle@pharmacy.ucsf.edu
Phone: 415-476-4958
Link to: Tobacco Control Policy Research
Pub Med Search: Bero LA |
Lisa A. Bero, PhD, Professor, Department of Clinical Pharmacy, School of Pharmacy and Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. She is Vice Chair in the Department of Clinical Pharmacy, and Chair of UCSF Conflict of Interest Committee. She has developed and validated methods for assessing the quality of research and scientific publication and measures influences of the quality of research, including university-industry relations. Dr. Bero has also conducted analyses to examine the dissemination and policy implications of scientific publications. She has published numerous peer-reviewed scientific articles related to her research as well as co-authored The Cigarette Papers (UC Press, 1996). Her international activities include: advisor to the World Health Organization, Drug Action Programme and Tobacco Free Initiative, advisor to the World Bank, recent member of the editorial board of the British Medical Journal, and Co-Director of the United States San Francisco Cochrane Center. She is a senior editor for Tobacco Control and editor for the Cochrane Effective Practice and Organization of Care Group – an international group of researchers conducting meta-analysis of the literature on interventions to change health professional behavior. She is a member of the 2005 WHO Expert Committee on the Selection and Use of Essential Medicines. She has also been elected as a member of the Cochrane Collaboration Steering Group and serves on several national committees related to technology assessment.
|
